Bercovier H, Ghittino C, Eldar A
Department of Clinical Microbiology, Hadassah Medical School, Hebrew University, Jerusalem, Israel.
Dev Biol Stand. 1997;90:153-60.
Streptococcal infections of fish have been reported from various parts of the world, including the Far East, the United States, South Africa, Australia, Israel and Europe. Classification of Gram-positive cocci (DNA-DNA hybridization studies coupled with 165 sequencing) has shown that at least five different defined species are pathogenic to fish, e.g. Streptococcus iniae (syn. S. shilot), Streptococcus difficile, Lactococcus garvieae (syn. Enterococcus seriolicida), Lactococcus piscium and Vagococcus salmoninarum. "Streptococcosis" of fish should therefore be regarded as a complex of similar diseases caused by different genera and species of Gram-positive cocci, each capable of inducing CNS damage, as well as various degrees of multisystem organ involvement. Panophthalmitis ("pop-eye") and meningitis/meningoencephalitis are the sole findings in trout infected by S. iniae and in tilapines infected by S. difficile. In contrast, L. garvieae-infected trout bear a systemic hyperacute infection with diffuse haemorrhages. Therapeutic measures are generally ineffective. Development of vaccines is therefore essential to control these diseases. In our studies, trout were vaccinated intraperitoneally with whole-cell formalin-inactivated S. iniae and L. garvieae and tilapines with whole-cell formalin-inactivated and acellular S. difficile extract. Under laboratory conditions, S. difficile-vaccinated tilapines were protected against a challenge of 100 LD50s. Protection was correlated with the development of specific agglutinins. Western blot analysis supported the hypothesis that only a few proteins act as protective antigens. S. iniae autovaccines were effective in preventing the disease in rainbow trout in Israel. Under field conditions, fish vaccinated at 50 g were protected for over four months. The qualitative analysis of the humoral response indicated that specific antibodies are directed against a few protein moieties. The fact that passive transfer of antibodies protected fish from experimental infection suggests that the basic mechanism of protection is antibody mediated. L. garvieae autovaccines developed for Italian trout farming were found to elicit a response similar to that of S. iniae. Despite the high virulence of L. garvieae (LD50 of 6 x 10(1) CFU/fish, compared with 3 x 10(4) CFU/fish of S. iniae), the protection against the experimentally induced disease lasted for five months under laboratory conditions, with survival rates of 80-90%. A single injection of the vaccine (0.1 ml/fish) resulted in specific antibody production detectable for six months. In the field, protection rates of 70-80% were obtained for a period of three months, in fish of 200-300 g reared at water temperatures of 18-21 degrees C.
世界各地均有鱼类链球菌感染的报道,包括远东地区、美国、南非、澳大利亚、以色列和欧洲。革兰氏阳性球菌的分类(DNA - DNA杂交研究结合165测序)表明,至少有五种不同的特定物种对鱼类具有致病性,例如海豚链球菌(同义词:希洛链球菌)、艰难链球菌、格氏乳球菌(同义词:杀鱼肠球菌)、鱼乳球菌和鲑鱼漫游球菌。因此,鱼类的“链球菌病”应被视为由革兰氏阳性球菌的不同属和种引起的一组相似疾病,每种都能导致中枢神经系统损伤以及不同程度的多系统器官受累。全眼球炎(“突眼症”)和脑膜炎/脑膜脑炎是感染海豚链球菌的鳟鱼以及感染艰难链球菌的罗非鱼的唯一症状。相比之下,感染格氏乳球菌的鳟鱼会出现全身性超急性感染并伴有弥漫性出血。治疗措施通常无效。因此,开发疫苗对于控制这些疾病至关重要。在我们的研究中,给鳟鱼腹腔注射全细胞福尔马林灭活的海豚链球菌和格氏乳球菌疫苗,给罗非鱼注射全细胞福尔马林灭活和无细胞的艰难链球菌提取物。在实验室条件下,接种艰难链球菌疫苗的罗非鱼对100个半数致死量的攻击具有抵抗力。保护作用与特异性凝集素的产生相关。蛋白质印迹分析支持了只有少数蛋白质作为保护性抗原的假说。海豚链球菌自身疫苗在以色列对虹鳟鱼预防该病有效。在田间条件下,50克重的接种疫苗的鱼能得到四个多月的保护。体液反应的定性分析表明,特异性抗体针对少数蛋白质部分。抗体的被动转移能保护鱼类免受实验性感染这一事实表明,保护的基本机制是抗体介导的。为意大利鳟鱼养殖开发的格氏乳球菌自身疫苗引发的反应与海豚链球菌相似。尽管格氏乳球菌的毒力很高(半数致死量为6×10¹CFU/鱼,而海豚链球菌为3×10⁴CFU/鱼),但在实验室条件下,对实验性诱导疾病的保护持续了五个月,存活率为80 - 90%。单次注射疫苗(0.1毫升/鱼)可使特异性抗体产生在六个月内可检测到。在田间条件下,对于水温为18 - 21摄氏度饲养的200 - 300克重的鱼,三个月内的保护率为70 - 80%。